Joel Lewis

CIK: 0001725595

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)12 (40.0%)

Position reduction

Option Exercises (M)11 (36.7%)

Derivative conversions

Awards (A)6 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (3.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GALT

GALECTIN THERAPEUTICS INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (30 total)

GALT
GALECTIN THERAPEUTICS INC
Jan 16, 2026
Award(A)
Stock option (right to buy)
Direct
91K shares-
GALT
GALECTIN THERAPEUTICS INC
Jan 16, 2026
Award(A)
Stock option (right to buy)
Direct
84K shares-
GALT
GALECTIN THERAPEUTICS INC
Jan 16, 2026
Award(A)
Restricted Stock Unit
Direct
120K shares-
GALT
GALECTIN THERAPEUTICS INC
Jan 6, 2026
Sale(S)
Direct
37.7K shares at avg. $3.58$135K
GALT
GALECTIN THERAPEUTICS INC
Jan 5, 2026
Unknown
Direct
56.3K shares at avg. $3.88$219K
GALT
GALECTIN THERAPEUTICS INC
Jan 5, 2026
Sale(S)
Direct
27.7K shares at avg. $3.91$108K
GALT
GALECTIN THERAPEUTICS INC
Jan 2, 2026
Exercise(M)
Direct
84K shares-
GALT
GALECTIN THERAPEUTICS INC
Jan 2, 2026
Sale(S)
Direct
18.6K shares at avg. $4.20$78K
GALT
GALECTIN THERAPEUTICS INC
Dec 17, 2025
Exercise(M)
Direct
7.8K shares at avg. $2.86$22K
GALT
GALECTIN THERAPEUTICS INC
Dec 17, 2025
Sale(S)
Direct
7.8K shares at avg. $7.06$55K
GALT
GALECTIN THERAPEUTICS INC
Nov 18, 2025
Exercise(M)
Direct
6.8K shares at avg. $2.39$16K
GALT
GALECTIN THERAPEUTICS INC
Nov 18, 2025
Sale(S)
Direct
6.8K shares at avg. $6.15$42K
GALT
GALECTIN THERAPEUTICS INC
Nov 17, 2025
Exercise(M)
Direct
15.7K shares at avg. $2.39$37K
GALT
GALECTIN THERAPEUTICS INC
Nov 17, 2025
Sale(S)
Direct
15.7K shares at avg. $6.04$95K
GALT
GALECTIN THERAPEUTICS INC
Nov 10, 2025
Exercise(M)
Direct
1.9K shares at avg. $2.39$4K
GALT
GALECTIN THERAPEUTICS INC
Nov 10, 2025
Sale(S)
Direct
1.9K shares at avg. $6.03$11K
GALT
GALECTIN THERAPEUTICS INC
Nov 5, 2025
Exercise(M)
Stock option (right to buy)
Direct
1.9K shares-
GALT
GALECTIN THERAPEUTICS INC
Nov 5, 2025
Sale(S)
Direct
200 shares at avg. $6.00$1K
GALT
GALECTIN THERAPEUTICS INC
Nov 5, 2025
Exercise(M)
Direct
200 shares at avg. $2.39$478
GALT
GALECTIN THERAPEUTICS INC
Nov 4, 2025
Sale(S)
Direct
14.4K shares at avg. $6.07$88K
GALT
GALECTIN THERAPEUTICS INC
Nov 4, 2025
Exercise(M)
Direct
14.4K shares at avg. $2.39$34K
GALT
GALECTIN THERAPEUTICS INC
Nov 3, 2025
Sale(S)
Direct
1.3K shares at avg. $6.01$8K
GALT
GALECTIN THERAPEUTICS INC
Nov 3, 2025
Exercise(M)
Direct
1.3K shares at avg. $2.39$3K
GALT
GALECTIN THERAPEUTICS INC
Sep 12, 2025
Exercise(M)
Direct
14K shares at avg. $2.39$33K
GALT
GALECTIN THERAPEUTICS INC
Sep 12, 2025
Sale(S)
Direct
14K shares at avg. $6.36$89K

		Type	Shares	Price		Ownership
Jan 16, 2026	GALT GALECTIN THERAPEUTICS INC	Award(A) Stock option (right to buy)	91,000	-	-	Direct
Jan 16, 2026	GALT GALECTIN THERAPEUTICS INC	Award(A) Stock option (right to buy)	84,000	-	-	Direct
Jan 16, 2026	GALT GALECTIN THERAPEUTICS INC	Award(A) Restricted Stock Unit	120,000	-	-	Direct
Jan 6, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	37,698	$3.58	$134,853	Direct
Jan 5, 2026	GALT GALECTIN THERAPEUTICS INC	Unknown	56,332	$3.88	$218,568	Direct
Jan 5, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	27,731	$3.91	$108,342	Direct
Jan 2, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	84,000	-	$0	Direct
Jan 2, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	18,571	$4.20	$77,939	Direct
Dec 17, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	7,829	$2.86	$22,391	Direct
Dec 17, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	7,829	$7.06	$55,241	Direct
Nov 18, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	6,783	$2.39	$16,211	Direct
Nov 18, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	6,783	$6.15	$41,723	Direct
Nov 17, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	15,680	$2.39	$37,475	Direct
Nov 17, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	15,680	$6.04	$94,643	Direct
Nov 10, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	1,867	$2.39	$4,462	Direct
Nov 10, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	1,867	$6.03	$11,252	Direct
Nov 5, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M) Stock option (right to buy)	1,867	-	-	Direct
Nov 5, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	200	$6.00	$1,200	Direct
Nov 5, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	200	$2.39	$478	Direct
Nov 4, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	14,420	$6.07	$87,529	Direct
Nov 4, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	14,420	$2.39	$34,464	Direct
Nov 3, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	1,300	$6.01	$7,813	Direct
Nov 3, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	1,300	$2.39	$3,107	Direct
Sep 12, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	14,000	$2.39	$33,460	Direct
Sep 12, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	14,000	$6.36	$89,048	Direct

1-25 of 30 transactions

About LEWIS JOEL

LEWIS JOEL (SEC CIK 0001725595) files insider reports with the SEC as President and CEO of GALECTIN THERAPEUTICS INC (GALT).

Signal8 holds 13 ownership filings by LEWIS JOEL, all Form 4s, filed between Dec 26, 2024 and Jan 22, 2026. Those filings report 30 transactions, from Dec 23, 2024 to Jan 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on LEWIS JOEL's filings is in NORCROSS, GA.

Recent filings by LEWIS JOEL

Jan 16, 2026: Grants or awards of GALT derivative securities (3 lines, Form 4, code A).
Jan 6, 2026: Open-market sale of GALT shares (Form 4, code S).
Jan 5, 2026: Transaction of GALT shares (Form 4).
Jan 5, 2026: Open-market sale of GALT shares (Form 4, code S).
Jan 2, 2026: Option exercise of GALT shares (Form 4, code M).

Other insiders filing for GALECTIN THERAPEUTICS INC (GALT)

Uihlein Richard E, Director
Jamil Khurram, Chief Medical Officer
Shlevin Harold H., Director
Brem Henry, Director
ELDRED KARY, Director
CARSON BENJAMIN SR, Director

How to read Form 4 transaction codes